Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.
07 March, 2021
2020 © MedGenome • All Rights Reserved
Request a quote
Customer Portal Login